Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2025)

Ultragenyx Pharmaceutical (RARE) has disclosed Tax Rate for 9 consecutive years, with 0.71% as the latest value for Q4 2025.

  • Quarterly Tax Rate fell 104.0% to 0.71% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.71% through Dec 2025, up 7429.0% year-over-year, with the annual reading at 0.71% for FY2025, 7429.0% up from the prior year.
  • Tax Rate for Q4 2025 was 0.71% at Ultragenyx Pharmaceutical, down from 0.49% in the prior quarter.
  • The five-year high for Tax Rate was 0.32% in Q4 2024, with the low at 2.63% in Q3 2022.
  • Average Tax Rate over 5 years is 0.5%, with a median of 0.37% recorded in 2021.
  • The sharpest move saw Tax Rate crashed -238bps in 2022, then surged 222bps in 2023.
  • Over 5 years, Tax Rate stood at 0.02% in 2021, then tumbled by -661bps to 0.12% in 2022, then plummeted by -560bps to 0.81% in 2023, then surged by 140bps to 0.32% in 2024, then crashed by -322bps to 0.71% in 2025.
  • According to Business Quant data, Tax Rate over the past three periods came in at 0.71%, 0.49%, and 0.83% for Q4 2025, Q3 2025, and Q2 2025 respectively.